-
Chemotherapeutic agents
drugs to treat a disease
-
Antimicrobial drugs
interfere with the growth of microbes within a host
-
Antibiotic
substance produced by a microbe that inhibits another microbe
-
Selective toxicity
a drug that kills harmful microbes without damaging the host
-
A look back
- began in 1909 with Paul Ehrlich
- arsenic compound for treatment of syphilis
- salvarsan
- 1929- Fleming discovered penicillin, produced by Penicillium mold
- cointed ter antibiotic
- 1932- Gerhard Domagk discovered sulfanilamide
- first to use agent to treat wide array of bacterial infections
- prontosil: red dye
-
Antibiotics
naturally produced antimicrobial agent
-
Semi-synthetics
chemically altered antibiotics that are more effective than naturally occurring one
-
Synthetics
completely synthesized in a lab
-
Narrowspectrum
an agent that works against a single gram negative, gram positive, or a few organisms
-
Broadspectrum
an agent that is effective against a wide variety of gram positive and gram negative organisms
-
Bacteriacidal
an agent that kills the organisms
-
Bacteriostatic
an agent that temporarily inhibits the growth of the organism long enough for the bodys defense mechanism to take over
-
Penicillin
selectively toxic, bacteriocidal
MOA: Competitively combine with transpeptidase(penicillan binding agent). Inhibits crosslinking of PTG. Cell wall synthesis is arrested and the bacteria dies
-
Methicillin (semisythetic) penicillin
- penicillin
- amoxicillin
- ampicillin
-
-
-
Resistance to beta-lactam antibiotics: What four ways do bacteria defend themselves from the PCN family?
- 1. alter porins
- 2. Gm+ and Gm- possess beta-lactamase enzymes that cleave beta-lactam ring (penicillinase)
- 3. alter structure of transpeptidase so antibiotics cant bind (methicillin-resistan staphylococcus aureus (MRSA))
- 4. Gm+ and Gm- may develop the ability to actively pump out beta-lactams before it binds to the transpeptidase
-
Beta-lactamase inhibitor enzymes
- they are given in combination with penicillins to create a beta-lactamase resistant combination
- Clavulanic acid
- amoxicillin and clavulanic acid: augmentin
- Sulbactam
- ampicillin and sulbactam: unasyn
- Tazobactam
- piperacillin and tazobactam: zosyn
-
Inhibitors of cell wall synthesis
- Bacitracin
- Vancomycin
- Isoniazid
-
Why is Isoniazid used in treating the genus Mycobacterium?
- members of the genus mycobacterium have an atypical cell wall that contain mycolic acid
- acid fast stain used to see it
- cause leprosy and tuberculosis
- Isoniazid (INH) inhibits the enzyme, fatty acid synthaseandis the drug of choice, generally used in combination with rifampin and ethambutol
-
Antifungal drugs inhibition of cell wall synthesis
- target synthesis of beta-glucans and result in an incomplete cell wall
- echinocandins
- binds to 1,3 b-glucan synthase
- used to treat candida and pneumocystis
- caspofungin (cancidas)
-
Polymyxin B
- made from a specific form of bacillus
- caues disruption of the plasma membrane by attaching to the phospholipids causing holes in PM
- effective against gram negative bacteria
- pseudomonas
- toxic to human kidneys
- topical
- combined with bacitracin and neomycin in over the counter preparation
-
Antifungal disruption of plasma membranes
- Amphotericin B
- attaches to ergosterol and dirupts membrane and causes lysis
- Azoles
- inhibits lanosterol a-demethylase
- enzyme converts lanosterol to ergosterol
- dirupts plasma membrane
- miconazole/clotrimazole
- triazoles (fluconazole and itraconazole)
-
Inhibitors of protein synthesis
- Chloramphenicol
- Aminoglycosides
- Tetracyclines
- Macrolides
- Antisense nucleic acids
-
Chloramphenicol
- Broad spectrum
- binds 50S subunit, inhibits peptide bond formation
- serious toxicity
- suppression of bone marrow
-
Aminoglycosides
- streptomycin, neomycin, gentamicin, tobramycin
- broad spectrum
- bind to 30S and cause misreading of mRNA
- toxicity can cause hearing impairment and/or kidney damage
-
Tetracyclines
- broad spectrum
- effective against Gram + and Gram-, rickettsias, and chlamydia
- interferes with tRNA attachment
- forms complexes with calcium and can strain developing teeth and affect strength of developing bones
-
Macrolides
- gram positives
- binds 50S, prevents translation
- erythromycin
- azithromycin
- clarithromycin
-
Antisense nucleic acids
- fomiversen
- cytomegalovirus and eye infections
- prevents formation of 70S initiation complex
- oxazolidinones (zyvox)
- vancomycin and methicillin-resistant staphylococcus aureus
-
Inhibition of metabolic pathways by competitive inhibition
- Sulfonamides (sulfa drugs)
- structural similar to PABA
- inhibit folic acid synthesis
- broad spectrum
-
Inhibition of nucleic acid synthesis
- compounds can interefere with function of nucleic acids (nucleoside analogs)
- nucleoside analogs can distort shapes of nucleic acid molecules and prevent further replication, transcription, or translation
- most often used agains viruses; viral DNA polymerases moer likely to incorporate and viral nucleic acid synthesis more rapid than that in host cells
- also effective agains rapidly dividing cancer cells
-
Inhibitors of nucleic acid synthesis rifampin
- Rifampin
- binds to bacterial RNA polymerase
- antituberculosis
- Quinolones and Fluroquinolones
- Inhibits DNA gyrase(uncoils DNA)
- Broader spectrum synthetic versions: ciproflaxin(anthrax) limited use in children
-
Antifungal drugs-inhibition of microtubules(mitosis)
- Griseofulvin
- produced by a species of penicillium
- used for superficial mycoses of hair and nail (tinea capitis or ringworm)
- binds slectively to keratin
- blocks microtubles and inhibits mitosis
- Tolnaftate
- mechanism of action: not known
- used for athletes foot
-
Anti-viral medicatons
- no peptidoglycan wall
- no ribosomes
- no plasma membrane
- current anti-viral medications attack steps in viral replication
- only attack actively replicating viruses
- most are fake viral nucleotides, derail viral replicaton
-
Antiviral drugs enzyme inhibitors
- Protease inhibitors
- Indinavir:
- prevents HIV protease to trim viral proteins down to working size
- prevents capsid formation
- Inhibit attachment
- Zanamivir
- influenza
- Inhibit uncoating
- Amantadine
- influenza
- Interferons prevent spread of viruses to new cells
- viral hepatitis
- Reverse transcriptase inhibitors: RNA to DNA
- HIV
-
Disk-diffusion test
- also known as the kirby-bauer test
- petri plate is "seeded" with test organism
- filter paper disks are impregnated with chemotherapeutic agents are place of surface
-
E test
- more advanced diffusion test
- can measure minimal inhibitory concentration (MIC)
-
Broth dilution test
- used to determine MIC
- plus minimal bactericidal concentration
- wells that show no growth (higher concentration than MIC) are cultured in drug free broth
- no growth= bacteriocidal
- growth= basteriostatic
-
Routes of administration
- topical: application of dug if infection is external
- oral: simplest; lower drug concentrations; no reliance on health care provider; patients do not always follow prescribing information
- intramuscular: requires needle; contration never as high as IV administration
- intravenous: requires needle or catheter; drug contration diminishes as liver and kidneys remove drug from circulation: must know how antimicrobial agent will be distributed to infected tissues
-
Toxicity
- exact cause of many adverse reactions poorly understood
- drgs may be toxic to kidneys, liver or nerves
- considerations needed when prescribing drugs to pregnant women
-
Allergies
- although allergic reactions are rare, they may be life threatening
- anaphylactic shock
- disruption of normal flora
-
Mechanisms of antibiotic resistance
- a variety of mutations can lead to antibiotic reistance such as:
- enzymatic destruction of drug
- prevention of penetration of dug
- alteration of dugs target site
- alter their metabolic activity
- rapid enjection of the drug
- mycobacterium tuberculosis produces MfpA protein, which binds to DNA gyrase preventing the binding of fluoroquinolone drugs
- resistance genese are often on plasmids or transposons that can be transferred between bacteria
-
How does antibiotic misuse cause antibiotic resistance?
- misuse of antibiotics selects for resistance mutants
- misuse includes:
- using outdated, weakened antibiotics
- using antibiotics for the common cold and other inappropriate conditions
- use of antibiotics in animal feed
- failure to complete the prescribed regimen
- using someone elses leftover prescription
-
How to fight against(retard) resistance?
- patient should finish entire course of antimicrobial
- limit use of antimicrobials to necessary cases
- use synergistic antimicrobials
- develop new variations of existing drugs: second-generation drugs and third-generation drugs
- search for new antibiotics, semi-synthetics, and synthetics
- bacteriocins
- design drugs complementary to the shape of microbial proteins to inhibit them
-
Bacitracin
- inhibits lipid carrier, bactoprenol
- prevents transport of NAM subunits through cell wall
- effective as a topical treatment against gram positives
- Staphylococci
- Streptococci
-
Vancomycin
- glycopeptide derived from streptomyces
- prevents insertion of NAMs and NAGs into PTG wall
- important "last line" against antibiotic resistant S. aureus
-
Zone of inhibition
No growth in the immediate area around the disc - the larger the zone the more sensitive the microbe is to the drug
-
Minimal inhibitory concentration (MIC)
lowest antibiotic concentration that prevents visible bacterial growth
|
|